Eosinophilic myocarditis and hypereosinophilic syndrome

Hanane Boussir1, Amine Ghalem1, Nabila Ismaili1

  • 1Department of Cardiology, University Hospital of Mohammed VI, Oujda, MoroccoMorocco.

Insights

Hypereosinophilic syndrome (HES) can cause severe cardiac damage. This case highlights a favorable outcome in a patient with eosinophilic myocarditis and cardiogenic shock through prompt, multi-faceted treatment.

Area of Science:

  • Hematology
  • Cardiology
  • Immunology

Background:

  • Hypereosinophilic syndrome (HES) is a rare hematological disorder.
  • Cardiac involvement in HES, though uncommon, significantly worsens prognosis.
  • Cardiac injury in HES progresses through infiltration, thrombosis, and fibrosis stages.

Purpose of the Study:

  • To report a case of hypereosinophilic syndrome with significant cardiac involvement.
  • To illustrate the management and outcome of eosinophilic myocarditis in cardiogenic shock.
  • To discuss the challenges and therapeutic approaches for cardiac HES.

Main Methods:

  • Case report of a 33-year-old female patient.
  • Diagnosis of HES with pulmonary, gastrointestinal, and cardiac involvement.
  • Treatment included dobutamine, anticoagulation, corticosteroids, beta-blockers, and ACE inhibitors.

Main Results:

  • The patient presented with eosinophilic myocarditis and cardiogenic shock.
  • A favorable clinical evolution was observed with the implemented treatment regimen.
  • This case demonstrates successful management of severe cardiac HES.

Conclusions:

  • Cardiac involvement in HES is a critical complication requiring aggressive management.
  • Corticosteroids remain a primary treatment, but combination therapies are essential.
  • Prompt diagnosis and multidisciplinary treatment can improve outcomes in HES-related cardiac injury.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
385
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
493
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
700
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
568
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
266